Stephen G. Ellis, MD, is the Section Head of Invasive/Interventional Cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He also is Co-Director and Co-Founder of the Cardiovascular Genebank. His primary clinical interests are complex coronary interventions, novel treatments for patients who are unable to have surgery, minimally invasive treatments for patients with aortic valve disease and studies to better understand the basis and predict the occurrence of disease (genomics and proteomics).
Specialty/Clinical interests: Coronary artery disease, stents, stent restenosis, total coronary occlusions, angioplasty, stent-coronary, coronary artery atherectomy, coronary intervention, drug-eluting stenting, aortic valve disease, percutaneous interventions, prevention of coronary artery disease
Number of Procedures Performed: Dr. Ellis has performed more than 4,000 complex coronary interventions throughout his career.
Success Rates: Cleveland Clinic has been ranked the #1 hospital for cardiology and heart surgery by U.S. News & World Report since 1994. Success rates for specific procedures are available at: http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx
Education and Training: Dr. Ellis received his medical degree from the University of California (at Los Angeles). He completed his internship and residency at Cedars-Sinai Medical Center, Los Angeles, and fellowships at the Brigham and Women's Hospital (Cardiology) in Boston, Stanford University (Cardiology) in Stanford, CA, and Emory University (Angioplasty) in Atlanta, GA. He has done additional work in Molecular Biology at Pennsylvania State University.
Research, Publications and Speaking: Dr. Ellis serves on the editorial boards for numerous publications, including the Journal of the American College of Cardiology American Journal of Cardiology, Circulation and the American Heart Journal. He has authored and co-authored more than 700 papers on interventional cardiology and cardiovascular disease for numerous scientific journals. Dr. Ellis also served as the principal investigator for many national and international clinical studies that have changed the approach to treatment of patients with coronary artery disease. These include the RESCUE I trial, GUSTO IIb PTCA study, TAXUS IV and V trials ,the FINESSE trial and the ABSORB III and IV trials.
About Dr. Ellis: “I enjoy my field because it’s especially gratifying to help patients whose conditions and treatment plans have been a challenge to other physicians. I also enjoy the opportunity to advance the field of medicine through research.”
Leisure time activities: In his spare time, Dr. Ellis enjoys reading, running, skiing, golfing and spending time with his family